NCT06477159 - Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

July 31, 2027

Conditions

Exocrine Pancreatic Insufficiency

Interventions

DRUG

Pancrelipase Capsules

Treatment with Pancreatic Enzyme Replacement Therapy

Trial Locations (5)

RECRUITING

New York University Langone Medical Center, New York

RECRUITING

University of Pittsburgh, Pittsburgh

RECRUITING

The Ohio State University, Columbus

RECRUITING

University of Illinois Chicago, Chicago

RECRUITING

University of Southern California, Los Angeles